Chronic kidney disease

Last updated: February 23, 2023

Chronic kidney disease

HNG 574

HNG 574

Gastroesophageal reflux disease (GERD)
Acid reducing medications
Introduction to the cranial nerves
Sleep apnea
Pancreatic secretion
Acute pancreatitis
Pancreatitis: Clinical
Skin cancer
Leg ulcers: Clinical
Peptic ulcers and stomach cancer: Clinical
Colorectal polyps
Colorectal cancer
Viral hepatitis: Clinical
Viral hepatitis: Pathology review
Seborrhoeic dermatitis
Wound healing
Stevens-Johnson syndrome
Folliculitis
Crohn disease
Alzheimer disease
Gastrointestinal system anatomy and physiology
Liver anatomy and physiology
Peptic ulcer
Celiac disease
Lactose intolerance
Ulcerative colitis
Viral hepatitis
Hepatocellular carcinoma
Gallstones
Acute cholecystitis
Appendicitis: Pathology review
Gallbladder disorders: Pathology review
Cirrhosis: Pathology review
Jaundice: Pathology review
Pancreatitis: Pathology review
Gastrointestinal bleeding: Pathology review
Diverticular disease: Pathology review
Inflammatory bowel disease: Pathology review
Skeletal system anatomy and physiology
Fibrous, cartilage, and synovial joints
Bone remodeling and repair
Slipped capital femoral epiphysis
Osgood-Schlatter disease (traction apophysitis)
Legg-Calve-Perthes disease
Transient synovitis
Rotator cuff tear
Carpal tunnel syndrome
Sprained ankle
Achilles tendon rupture
Spinal disc herniation
Degenerative disc disease
Sciatica
Rhabdomyolysis
Osteomyelitis
Osteoporosis
Osteoarthritis
Rheumatoid arthritis
Gout
Psoriatic arthritis
Reactive arthritis
Ankylosing spondylitis
Polymyalgia rheumatica
Fibromyalgia
Myasthenia gravis
Sjogren syndrome
Systemic lupus erythematosus
Antiphospholipid syndrome
Raynaud phenomenon
Scleroderma
Rheumatoid arthritis and osteoarthritis: Pathology review
Back pain: Pathology review
Systemic lupus erythematosus (SLE): Pathology review
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid agonists, mixed agonist-antagonists and partial agonists
Antigout medications
Osteoporosis medications
Cranial nerve pathways
Nervous system anatomy and physiology
Cranial nerves
Sympathetic nervous system
Chiari malformation
Cerebral palsy
Tethered spinal cord syndrome
Transient ischemic attack
Ischemic stroke
Arteriovenous malformation
Wernicke-Korsakoff syndrome
Concussion and traumatic brain injury
Seizures and epilepsy
Tension headache
Migraine
Trigeminal neuralgia
Cluster headache
Idiopathic intracranial hypertension
Vascular dementia
Dementia with Lewy bodies
Parkinson disease
Multiple sclerosis
Transverse myelitis
Acoustic neuroma (schwannoma)
Adult brain tumors
Treponema pallidum (Syphilis)
Vitamin B12 deficiency
Cauda equina syndrome
Guillain-Barre syndrome
Bell palsy
Headaches: Pathology review
Seizures: Pathology review
Dementia: Pathology review
Cholinergic receptors
Migraine medications
Anti-parkinson medications
Psoriasis
Erythema multiforme
Pressure ulcer
Cellulitis
Varicella zoster virus
Herpes simplex virus
Sarcoptes scabiei (Scabies)
Human herpesvirus 8 (Kaposi sarcoma)
Onychomycosis
Skin cancer: Pathology review
Acneiform skin disorders: Pathology review
Anatomy clinical correlates: Male pelvis and perineum
Anatomy clinical correlates: Female pelvis and perineum
Renal system anatomy and physiology
Renal clearance
Renin-angiotensin-aldosterone system
Lupus nephritis
Kidney stones
Hydronephrosis
Acute pyelonephritis
Chronic kidney disease
Polycystic kidney disease
Renal artery stenosis
Hypospadias and epispadias
Urinary incontinence
Lower urinary tract infection
Prostate gland histology
Syncope: Clinical
Demyelinating disorders: Pathology review
Seizures: Clinical
Stroke: Clinical
Vertigo: Pathology review

Flashcards

Chronic kidney disease

0 of 16 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 1 complete

A 50-year-old man comes to the office because of generalized weakness for several months. His past medical history includes hypertension and type 1 diabetes mellitus. His renal function has gradually declined over the past three years. Current medications include carvedilol, insulin, and calcitriol. Physical examination demonstrates an ill-appearing male with pale conjunctiva, mucosal pallor and 2+ bilateral lower extremity edema. Glomerular filtration rate assessed 3 months ago was 40 mL/min/1.73 m2 (reference range: 90-120 mL/min/1.73 m2). Hemoglobin is 9 g/dL (13.5-17.5 g/dL). The remainder of the laboratory evaluation is demonstrated below.
 
 Laboratory value  Results  Reference range 
 Serum chemistry  
 Sodium  132 mEq/L  136-146 mEq/L 
 Potassium  4.2 mEq/L  3.5-5 mEq/L 
 Chloride  95 mEq/L  95-105 mEq/L 
 Magnesium  1.7 mEq/L  1.5-2 mEq/L 
 Creatinine  6 mg/dL  0.6-1.2 mg/dL 
 Blood urea nitrogen  70 mg/dL  7-18 mg/dL 
 Serum 25-OH Vitamin D (D2)  45 ng/mL  25-80 ng/mL 
 Serum 1,25-OH Vitamin D (D3)  30 pg/mL  18-64 pg/mL 

Which of the following additional sets of laboratory findings are most likely to be observed in this patient?  

Transcript

Watch video only

Chronic kidney disease is a broad term that includes subtle decreases in kidney function that develop over a minimum of three months.

In contrast, acute kidney injury refers to any deterioration in kidney function that happens in less than three months.

Now the kidney’s job is to regulate what’s in the blood, so they might remove waste, or make sure electrolyte levels are steady, or regulate the overall amount of water, and even make hormones - the kidneys do a lot of stuff!

Blood gets into the kidney through the renal artery, and once inside it goes gets into tiny clumps of arterioles called glomeruli where it’s initially filtered, and the filtrate which is the stuff that gets filtered out, moves into the renal tubule.

The rate at which this filtration takes place is known as glomerular filtration rate or GFR. In a normal healthy person, this is somewhere around 100-120 milliliter of fluid filtered per minute per 1.73 m2 of body surface area. The value is slightly less in women than men and it decreases slowly in all of us as we grow older.

One of the most common causes of chronic kidney disease is hypertension.

In hypertension, the walls of arteries supplying the kidney begin to thicken in order to withstand the pressure, and that results in a narrow lumen. A narrow lumen means less blood and oxygen gets delivered to the kidney, resulting in ischemic injury to the nephron’s glomerulus.

Immune cells like macrophages and fat-laden macrophages called foam cells slip into the damage glomerulus and start secreting growth factors like Transforming Growth Factor ß1 or TGF-ß1.

These growth factors cause the mesangial cells to regress back to their more immature stem cell state known as mesangioblasts and secrete extracellular structural matrix. This excessive extracellular matrix leads to glomerulosclerosis, hardening and scarr, and diminishes the nephron’s ability to filter the blood - over time leading to chronic kidney disease.

The most common cause of CKD is diabetes, excess glucose in the blood starts sticking to proteins in the blood — a process called non-enzymatic glycation because no enzymes are involved.

This process of glycation particularly affects the efferent arteriole and causes it to get stiff and more narrow - a process called hyaline arteriosclerosis. This creates an obstruction that makes it difficult for blood to leave the glomerulus, and increases pressure within the glomerulus leading to hyperfiltration.

In response to this high-pressure state, the supportive mesangial cells secrete more and more structural matrix expanding the size of the glomerulus.

Over many years, this process of glomerulosclerosis, once again, diminishes the nephron’s ability to filter the blood and leads to chronic kidney disease.

Although diabetes and hypertension are responsible for the vast majority of CKD cases, there are other systemic diseases like lupus and rheumatoid arthritis, can also cause glomerulosclerosis.

Other causes of chronic kidney disease include infections like HIV, as well as long-term use of medications like NSAIDs, and toxins like the ones in tobacco.

Now, normally urea in the body gets excreted in the urine, but when there’s a decreased glomerular filtration fate, less urea get filtered out, and therefore it accumulates in the blood, a condition called azotemia, which can cause general symptoms like It nausea and a loss of appetite.

As the toxin levels really build up, they can affect the functioning of the central nervous system - causing encephalopathy. This results in asterixis, a tremor of the hand that kind of resembles a bird flapping its wings and is best seen when the person attempts to extend their wrists.

Further accumulation of these toxins in the brain can even progress to coma and death.